Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Extracorporeal liver support: a continuing challenge.

Ram M Subramanian1, John A Kellum

  • 1Department of Pulmonary & Critical Care, University of Chicago, Chicago, IL 60637, USA.

Critical Care (London, England)
|February 8, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Net Ultrafiltration Prescription and Practice Among Critically Ill Patients Receiving Renal Replacement Therapy: A Multinational Survey of Critical Care Practitioners.

Critical care medicine·2020
Same author

A Multinational Observational Study Exploring Adherence With the Kidney Disease: Improving Global Outcomes Recommendations for Prevention of Acute Kidney Injury After Cardiac Surgery.

Anesthesia and analgesia·2020
Same author

Community Health Care Quality Standards to Prevent Acute Kidney Injury and Its Consequences.

The American journal of medicine·2019
Same author

Lung-kidney interactions in critically ill patients: consensus report of the Acute Disease Quality Initiative (ADQI) 21 Workgroup.

Intensive care medicine·2019
Same author

Baseline tubular biomarkers in young adults with congenital heart disease as compared to healthy young adults: Detecting subclinical kidney injury.

Congenital heart disease·2019
Same author

Acute kidney injury.

Lancet (London, England)·2019
Same journal

45th International Symposium on Intensive Care & Emergency Medicine.

Critical care (London, England)·2026
Same journal

High-resolution monitoring reveals fragmented 24-hour light exposure in intensive care units.

Critical care (London, England)·2026
Same journal

Coronary microvascular function in patients with sepsis and myocardial injury: an invasive coronary physiology study.

Critical care (London, England)·2026
Same journal

Comparative performance of mitral E/e' versus inferior vena cava variability for predicting fluid responsiveness in mechanically ventilated adults with shock.

Critical care (London, England)·2026
Same journal

Different lungs or different patients? Insights into postoperative ARDS.

Critical care (London, England)·2026
Same journal

Predictive validity of SOFA-2: analytical and contextual considerations.

Critical care (London, England)·2026
See all related articles

Artificial albumin dialysis shows conflicting results for acute on chronic liver failure. These systems may not reduce inflammatory cytokines, suggesting other mechanisms drive clinical improvement in liver failure patients.

Area of Science:

  • Hepatology
  • Biomedical Engineering

Background:

  • Liver failure presents a significant clinical challenge.
  • Hepatic dialysis, particularly artificial albumin dialysis, is being investigated for acute on chronic liver failure.
  • Existing research on albumin dialysis efficacy yields conflicting outcomes.

Discussion:

  • Albumin dialysis systems show limited impact on reducing serum inflammatory cytokines in severe acute on chronic liver failure.
  • The observed clinical improvements, if any, may stem from mechanisms beyond cytokine reduction.

Key Insights:

  • Artificial albumin dialysis efficacy in acute on chronic liver failure is debated.
  • A significant decrease in inflammatory cytokines is not consistently observed with albumin dialysis.
  • Alternative therapeutic pathways are likely responsible for any clinical benefits.

Related Experiment Videos

Outlook:

  • Further research is needed to elucidate the precise therapeutic mechanisms of albumin dialysis in liver failure.
  • Exploring non-cytokine-related pathways could lead to improved liver support strategies.
  • Understanding these alternative mechanisms is crucial for advancing liver failure treatment.